- Lipocine Announces Financial Results For The Year Ended December 31, 2020
- Lipocine To Present At M Vest / Maxim Conference And At The Lytham Partners Conference
- Lipocine Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis
- Lipocine Announces Presentations on TLANDO™ at ENDO 2021 Conference
- Lipocine to Present at Two Upcoming Investor Conferences
- Lipocine Closes Underwritten Public Offering Of Common Stock
- Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock
- Lipocine Announces Launch Of Public Offering Of Common Stock
Lipocine Inc (2VT:DUS) closed at 1.15, 17.35% above the 52 week low of 0.98 set on Nov 02, 2020.
0.98Nov 02 20201.91Jan 22 2021
Markit short selling activity
|Market cap||128.90m USD|
|EPS (TTM)||-0.4017 |
Data delayed at least 15 minutes, as of Apr 16 2021 18:30 BST.